BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34155063)

  • 1. Genital Powder Use and Risk of Epithelial Ovarian Cancer in the Ovarian Cancer in Women of African Ancestry Consortium.
    Davis CP; Bandera EV; Bethea TN; Camacho F; Joslin CE; Wu AH; Beeghly-Fadiel A; Moorman PG; Myers ER; Ochs-Balcom HM; Peres LC; Rosenow WT; Setiawan VW; Rosenberg L; Schildkraut JM; Harris HR
    Cancer Epidemiol Biomarkers Prev; 2021 Sep; 30(9):1660-1668. PubMed ID: 34155063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls.
    Terry KL; Karageorgi S; Shvetsov YB; Merritt MA; Lurie G; Thompson PJ; Carney ME; Weber RP; Akushevich L; Lo-Ciganic WH; Cushing-Haugen K; Sieh W; Moysich K; Doherty JA; Nagle CM; Berchuck A; Pearce CL; Pike M; Ness RB; Webb PM; ; ; Rossing MA; Schildkraut J; Risch H; Goodman MT;
    Cancer Prev Res (Phila); 2013 Aug; 6(8):811-21. PubMed ID: 23761272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Powder Use in the Genital Area With Risk of Ovarian Cancer.
    O'Brien KM; Tworoger SS; Harris HR; Anderson GL; Weinberg CR; Trabert B; Kaunitz AM; D'Aloisio AA; Sandler DP; Wentzensen N
    JAMA; 2020 Jan; 323(1):49-59. PubMed ID: 31910280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Body Powder Use and Ovarian Cancer: The African American Cancer Epidemiology Study (AACES).
    Schildkraut JM; Abbott SE; Alberg AJ; Bandera EV; Barnholtz-Sloan JS; Bondy ML; Cote ML; Funkhouser E; Peres LC; Peters ES; Schwartz AG; Terry P; Crankshaw S; Camacho F; Wang F; Moorman PG
    Cancer Epidemiol Biomarkers Prev; 2016 Oct; 25(10):1411-1417. PubMed ID: 27197282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First- and second-degree family history of ovarian and breast cancer in relation to risk of invasive ovarian cancer in African American and white women.
    Bethea TN; Ochs-Balcom HM; Bandera EV; Beeghly-Fadiel A; Camacho F; Chyn D; Cloyd EK; Harris HR; Joslin CE; Myers E; Moorman PG; Peres LC; Rosenow W; Setiawan VW; Wu AH; Rosenberg L; Schildkraut JM
    Int J Cancer; 2021 Jun; 148(12):2964-2973. PubMed ID: 33521947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign gynecologic conditions are associated with ovarian cancer risk in African-American women: a case-control study.
    Park HK; Schildkraut JM; Alberg AJ; Bandera EV; Barnholtz-Sloan JS; Bondy M; Crankshaw S; Funkhouser E; Moorman PG; Peters ES; Terry P; Wang F; Ruterbusch JJ; Schwartz AG; Cote ML
    Cancer Causes Control; 2018 Nov; 29(11):1081-1091. PubMed ID: 30269307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perineal powder exposure and the risk of ovarian cancer.
    Cook LS; Kamb ML; Weiss NS
    Am J Epidemiol; 1997 Mar; 145(5):459-65. PubMed ID: 9048520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiometabolic comorbidities and epithelial ovarian cancer risk among African-American women in the African-American Cancer Epidemiology Study (AACES).
    Staples JN; Peres LC; Camacho F; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy ML; Cote ML; Funkhouser E; Moorman PG; Peters ES; Schwartz AG; Terry PD; Schildkraut JM
    Gynecol Oncol; 2020 Jul; 158(1):123-129. PubMed ID: 32362566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive factors and ovarian cancer risk in African-American women.
    Moorman PG; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy M; Cote ML; Funkhouser E; Peters ES; Schwartz AG; Terry P; Crankshaw S; Wang F; Schildkraut JM
    Ann Epidemiol; 2016 Sep; 26(9):654-62. PubMed ID: 27528178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genital talc exposure and risk of ovarian cancer.
    Cramer DW; Liberman RF; Titus-Ernstoff L; Welch WR; Greenberg ER; Baron JA; Harlow BL
    Int J Cancer; 1999 May; 81(3):351-6. PubMed ID: 10209948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perineal exposure to talc and ovarian cancer risk.
    Harlow BL; Cramer DW; Bell DA; Welch WR
    Obstet Gynecol; 1992 Jul; 80(1):19-26. PubMed ID: 1603491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Talc, body powder, and ovarian cancer: A summary of the epidemiologic evidence.
    Wentzensen N; O'Brien KM
    Gynecol Oncol; 2021 Oct; 163(1):199-208. PubMed ID: 34366148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Talc powder and ovarian cancer: what is the evidence?
    Micha JP; Rettenmaier MA; Bohart R; Goldstein BH
    Arch Gynecol Obstet; 2022 Oct; 306(4):931-933. PubMed ID: 35348830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genital powder exposure and the risk of epithelial ovarian cancer.
    Rosenblatt KA; Weiss NS; Cushing-Haugen KL; Wicklund KG; Rossing MA
    Cancer Causes Control; 2011 May; 22(5):737-42. PubMed ID: 21516319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. African American women with advanced-stage ovarian cancer have worse outcomes regardless of treatment type.
    Whitmore G; Ramzan A; Sheeder J; Guntupalli SR
    Int J Gynecol Cancer; 2020 Jul; 30(7):1018-1025. PubMed ID: 32107316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial Differences in Population Attributable Risk for Epithelial Ovarian Cancer in the OCWAA Consortium.
    Peres LC; Bethea TN; Camacho TF; Bandera EV; Beeghly-Fadiel A; Chyn DL; Harris HR; Joslin CE; Moorman PG; Myers E; Ochs-Balcom HM; Rosenow W; Setiawan VW; Wu AH; Rosenberg L; Schildkraut JM
    J Natl Cancer Inst; 2021 Jun; 113(6):710-718. PubMed ID: 33252629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian cancer risk factors in African-American and white women.
    Moorman PG; Palmieri RT; Akushevich L; Berchuck A; Schildkraut JM
    Am J Epidemiol; 2009 Sep; 170(5):598-606. PubMed ID: 19605513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.
    Peres LC; Risch H; Terry KL; Webb PM; Goodman MT; Wu AH; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy ML; Cote ML; Funkhouser E; Moorman PG; Peters ES; Schwartz AG; Terry PD; Manichaikul A; Abbott SE; Camacho F; Jordan SJ; Nagle CM; ; Rossing MA; Doherty JA; Modugno F; Moysich K; Ness R; Berchuck A; Cook L; Le N; Brooks-Wilson A; Sieh W; Whittemore A; McGuire V; Rothstein J; Anton-Culver H; Ziogas A; Pearce CL; Tseng C; Pike M; Schildkraut JM;
    Int J Epidemiol; 2018 Apr; 47(2):460-472. PubMed ID: 29211900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of risk factors for ovarian cancer in women with and without endometriosis.
    Phung MT; Muthukumar A; Trabert B; Webb PM; Jordan SJ; Terry KL; Cramer DW; Titus LJ; Risch HA; Doherty JA; Harris HR; Goodman MT; Modugno F; Moysich KB; Jensen A; Kjaer SK; Anton-Culver H; Ziogas A; Berchuck A; Khoja L; Wu AH; Pike MC; Pearce CL; Lee AW
    Fertil Steril; 2022 Nov; 118(5):960-969. PubMed ID: 36182623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian Cancer in Women of African Ancestry (OCWAA) consortium: a resource of harmonized data from eight epidemiologic studies of African American and white women.
    Schildkraut JM; Peres LC; Bethea TN; Camacho F; Chyn D; Cloyd EK; Bandera EV; Beeghly-Fadiel A; Lipworth L; Joslin CE; Davis FG; Moorman PG; Myers E; Ochs-Balcom HM; Setiawan VW; Pike MC; Wu AH; Rosenberg L
    Cancer Causes Control; 2019 Sep; 30(9):967-978. PubMed ID: 31236792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.